First Lexington Corp.

Synta Pharmaceuticals Announces Encouraging Results for Elesclomol in AML In Vitro and Patient Ex-Vivo Studies Presented at ASH.(Clinical report)
Business Wire; 12/7/2009; 1109 words; ...support clinical evaluation in AML LEXINGTON, Mass. -- Synta Pharmaceuticals Corp. (NASDAQ: SNTA), a biopharmaceutical...New Orleans. Elesclomol is a first-in-class oxidative stress...Pharmaceuticals Synta Pharmaceuticals Corp. is a biopharmaceutical company...

Automakers go green, but who's buying? [Correction 12/9/09] ; Alt-fuel vehicles in the spotlight at car show, but their appeal to consumers is still limited
The Boston Globe; 12/4/2009; 1033 words; ...from Tesla Motors to BMW's first hybrid, the crossover ActiveHybrid...Wolkonowicz, of IHS Global Insight in Lexington. One of the loan recipients...BMW will be showing off its first hybrid at this year's Boston...hybrid; and General Motors Corp. is offering a number of sport...

Clinic Roundup.
BIOWORLD Today; 12/4/2009; 1062 words; ...of heart failure. The first two dose groups (out...Pharmaceuticals Inc., of Lexington, Mass., announced...Generex Biotechnology Corp., of Worcester, Mass...Francisco, said the first patient has been enrolled...colitis. This is the first of two induction trials...

Dyax's Kalbitor OK'd; Berinert Could Be Hurt in Acute HAE.
BIOWORLD Today; 12/3/2009; 1117 words; Assistant Managing Editor Dyax Corp. is set to launch Kalbitor (ecallantide...attacks of hereditary angioedema in the first quarter of next year after the drug cleared...angioedema. Dyax also has deals with Lexington, Mass.-based Cubist Pharmaceuticals...

Other News To Note.
BIOWORLD Today; 12/2/2009; 1549 words; ...biomedical companies. o Galenea Corp., of Cambridge, Mass...it expects to evaluate the first sequencing data shortly. o Helicos BioSciences Corp., of Cambridge, Mass...portfolio of compounds from Lexington, Mass.-based Epix Pharmaceuticals...